A collaborative funding opportunity
To date, four COVID-19 vaccines have been approved for use in Canada and priority populations are already receiving their vaccinations. However, critical questions remain around the vaccines’ performance, access, and public perception that need evidence-based answers from BC researchers.
As research funders, Genome BC, the Michael Smith Foundation for Health Research (MSFHR), and the BCCDC Foundation for Public Health have joined forces to support BC based research that addresses, and implements solutions for, knowledge gaps around COVID-19 vaccination.
We solicit BC-based research solutions in priority areas that build on existing research efforts and carry significant potential for fast impact on the current COVID-19 pandemic in BC.